Description

Specific drug interaction studies have not been conducted with Difluprednate 0.05% ophthalmic emulsion.

Adverse reactions associated with ophthalmic steroids include elevated intraocular pressure, which may be associated with optic nerve damage, visual acuity and field defects; posterior subcapsular cataract formation; secondary ocular infection from pathogens including herpes simplex, and perforation of the globe where there is thinning of the cornea or sclera. Ocular adverse reactions occurring with Difluprednate included corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, and blepharitis for patient with ocular surgery.

Pregnancy Category C. Difluprednate has been shown to be embryotoxic and teratogenic when administered subcutaneously to rabbits. Since use of Difluprednate during human pregnancy has not been evaluated so Difluprednate should be used during pregnancy only if the potential benefit justifies the potential risk to the embryo or fetus. It is not known whether use of Difluprednate passes into breast milk. Caution should be exercised when it is administered to a nursing mothers.

Prolonged use of corticosteroids may result in glaucoma & posterior subcapsular cataract formation. If this product is used for 10 days or longer, IOP should be monitored. Use of a corticosteroid medication in the treatment of patients with a history of herpes simplex requires great caution. Fungal infections of the cornea are particularly prone to develop coincidentally with long-term local steroid application. Do not touch dropper tip to any surface as this may contaminate this preparation.

Pediatric Use: Difluprednate was evaluated in 0 to 3 years of age for the treatment of inflammation following cataract surgery. A similar safety profile was observed in pediatric patients comparing Difluprednate to Prednisolone Acetate ophthalmic suspension 1%. Geriatric Use: No overall differences in safety or effectiveness have been observed between elderly and younger patients.

Overdosage will not ordinarily cause acute problems. If accidentally ingested, drink fluids to dilute.

Ophthalmic Steroid preparations